Valerie Morisset Eliem Therapeutics, Inc. (ELYM) insider trading activity

Valerie Morisset is EVP, R&D AND CSO of Eliem Therapeutics, Inc.. Currently has a direct ownership of 31,317 shares of ELYM, which is worth approximately $128,712. The most recent transaction as insider was on Jul 22, 2024, when has been sold 69,005 shares (Common Stock) at a price of $8.03 per share, resulting in proceeds of $554,110. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 31.3K

0% 3M change

93.58% 12M change

Total Value Held $128,712

Valerie Morisset Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 22 2024	SELL Open market or private sale	$554,110 $8.03 p/Share	69,005 Reduced 68.78%	31,317 Common Stock
Jul 19 2024	SELL Open market or private sale	$431,641 $7.17 p/Share	60,201 Reduced 37.5%	100,322 Common Stock
Jul 18 2024	SELL Open market or private sale	$267,331 $6.93 p/Share	38,576 Reduced 19.38%	160,523 Common Stock
Jul 17 2024	SELL Open market or private sale	$22,160 $6.91 p/Share	3,207 Reduced 1.59%	199,099 Common Stock
Jul 16 2024	SELL Open market or private sale	$356,500 $7.13 p/Share	50,000 Reduced 19.82%	202,306 Common Stock
Jul 15 2024	SELL Open market or private sale	$297,062 $7.01 p/Share	42,377 Reduced 14.38%	252,306 Common Stock
Jul 12 2024	SELL Open market or private sale	$353,500 $7.07 p/Share	50,000 Reduced 14.51%	294,683 Common Stock
Jul 11 2024	SELL Open market or private sale	$355,500 $7.11 p/Share	50,000 Reduced 12.67%	344,683 Common Stock
Jul 10 2024	SELL Open market or private sale	$341,500 $6.83 p/Share	50,000 Reduced 11.24%	394,683 Common Stock
Jul 09 2024	SELL Open market or private sale	$39,500 $6.66 p/Share	5,931 Reduced 1.32%	444,683 Common Stock
Jul 05 2024	SELL Open market or private sale	$87,134 $7.06 p/Share	12,342 Reduced 2.67%	450,614 Common Stock
Jul 03 2024	SELL Open market or private sale	$338,000 $6.76 p/Share	50,000 Reduced 9.75%	462,956 Common Stock
Jul 01 2024	BUY Exercise of conversion of derivative security	-	7,649 Added 1.47%	512,956 Common Stock
Apr 05 2024	BUY Exercise of conversion of derivative security	-	17,847 Added 3.41%	505,307 Common Stock
Sep 20 2023	BUY Exercise of conversion of derivative security	-	20,728 Added 4.08%	487,460 Common Stock
Mar 10 2023	BUY Exercise of conversion of derivative security	-	316,410 Added 40.4%	466,732 Common Stock

Valerie Morisset

EVP, R&D AND CSO

Redmond, WA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ELYM shares.

Notify only if

Value

Insider Trading

Get notified when an Eliem Therapeutics, Inc. insider buys or sells ELYM shares.

Notify only if

Operation

Value

Type

News

Receive news related to Eliem Therapeutics, Inc.

Track Activities on ELYM

Account